文献速递肺结节与肺癌

退伍军人管理局肺癌筛查示范项目中的筛查依从性

Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project.
PubMed 文献 · Chest · 2020-05-19

该研究对八个退伍军人事务医疗中心肺癌筛查示范项目进行二次数据分析,共筛查2103例患者。基线扫描至第一次随访扫描的依从性为82.2%,第一次至第二次随访为65.2%。存在结节和筛查站点可预测依从性,各站点间依从性差异显著(T1为63%至94%,T2为52%至82%,P < .05)。

要点

  • 基线至第一次随访低剂量CT依从性为82.2%,第一次至第二次随访降至65.2%。
  • 存在肺结节和筛查站点是依从性的预测因素。
  • 八个站点间依从性差异显著,需主动随访策略优化依从性。

核心结论

  • 尽管采用集中化项目设计并配备导航员和登记系统,站点间依从性变异仍显著,需主动随访策略以优化年度肺癌筛查依从性。
  • 为实现肺癌筛查的死亡率获益,年度筛查依从性须达到更高水平。

研究设计与样本

  • 对在八个退伍军人事务医疗中心开展的肺癌筛查示范项目进行二次数据分析,共筛查2103例患者。

主要发现

  • 从基线扫描(T0)至第一次随访扫描(T1)的筛查依从性为82.2%,从T1至第二次随访扫描(T2)为65.2%。
  • 经过三轮筛查后,1343例(64%)接受基线筛查的患者完成了两次后续年度低剂量CT;225例(11%)仅有一次后续低剂量CT;0.4%无T1扫描但有T2扫描;70例(3%)死亡;36例(1.7%)诊断为肺癌。
  • 逻辑回归模型显示存在结节和肺癌筛查站点可预测依从性。
  • 八个站点间筛查依从性差异显著,T1范围为63%至94%,T2范围为52%至82%(P < .05)。

临床怎么用

  • 应识别依从性低的站点和患者因素(如无结节),采取主动随访策略提高年度低剂量CT筛查依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adherence to annual low-dose CT was 95% in the National Lung Screening Trial and must be replicated to achieve mortality benefit from screening. RESEARCH QUESTION: How do we determine adherence rates within the Veterans Affairs Lung Cancer Screening Demonstration Project and identify factors predictive of adherence? STUDY DESIGN AND METHODS: A secondary data analysis of the Lung Cancer Screening Demonstration Project that was conducted at eight Veterans Affairs medical centers was performed to determine adherence to follow up imaging and to determine factors predictive of adherence. RESULTS: A total of 2,103 patients were screened. The adherence to screening from baseline scan (T0) to first follow-up scan (T1) was 82.2% and 65.2% from T1 to second follow-up scan (T2). Logistic regression modeling showed that presence of a nodule and the site of lung cancer screening were predictive of adherence. After three rounds of screening, 1,343 patients (64%) who underwent baseline screening underwent both subsequent annual low-dose CT scans; 225 patients (11%) had only one subsequent low-dose CT; 0.4% did not have a T1 scan but did have a T2 scan; 70 patients (3%) died, and 36 patients (1.7%) were diagnosed with lung cancer. There was significant variation in screening adherence across the eight sites, which ranged from 63% to 94% at T1 and 52% to 82% at T2 (P < .05). INTERPRETATION: Despite a centralized program design with dedicated navigator and registry to assist with adherence to annual lung cancer screening, variations between sites suggest that active follow-up strategies are needed to optimize adherence. For the mortality benefit from lung cancer screening to be recognized, adherence to annual screening must achieve higher rates.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Tanner NT, Brasher PB, Wojciechowski B, et al. Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020. PMID: 32439505. doi:10.1016/j.chest.2020.04.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。